The mechanism of action of Botulinum toxin type A in focal dystonia is most probably through its dual effect on efferent (motor) and afferent pathways at the injected site

This publication has 32 references indexed in Scilit:

• Botulinum toxin in the treatment of myofascial pain syndrome
  Pain, 1994
• BOTULINUM TOXIN IN THE MANAGEMENT OF THE LOWER LIMB IN CEREBRAL PALSY
  Developmental Medicine and Child Neurology, 1994
• Treatment of Myofascial Pain with Botulinum A Toxin
  Anesthesiology, 1994
• Botulinum Toxin in the Treatment of Neurological Disorders
  Annals of the New York Academy of Sciences, 1994
• Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25
  Nature, 1993
• Significant improvement of stiff‐person syndrome after paraspinal injection of botulinum toxin A
  Movement Disorders, 1993
• Clinical and polymyographic investigation of spasmodic torticollis
  Zeitschrift für Neurologie, 1992
• Assessment [RETIRED]
  Neurology, 1990
• Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
  Movement Disorders, 1987
• The results of direct injections of botulinum toxin into the central nervous system of rabbits
  The Journal of Physiology, 1953